These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7669179)

  • 1. Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes.
    Giardina G; Clarke GD; Grugni M; Sbacchi M; Vecchietti V
    Farmaco; 1995 Jun; 50(6):405-18. PubMed ID: 7669179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally-acting opioids.
    Smith HS
    Pain Physician; 2008 Mar; 11(2 Suppl):S121-32. PubMed ID: 18443636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.
    Singh N; Nolan TL; McCurdy CR
    J Mol Graph Model; 2008 Sep; 27(2):131-9. PubMed ID: 18456526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral kappa-opioid agonists for visceral pain.
    Rivière PJ
    Br J Pharmacol; 2004 Apr; 141(8):1331-4. PubMed ID: 15051626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
    Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
    Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analgesic effect of kappa-opioid receptor agonist].
    Ikeda Y; Matsumoto K
    Nihon Rinsho; 2001 Sep; 59(9):1681-7. PubMed ID: 11554036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery, stereospecific characterization and peripheral modification of 1-(pyrrolidin-1-ylmethyl)-2-[(6-chloro-3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinolines as novel selective κ opioid receptor agonists.
    Gan ZJ; Wang YH; Xu YG; Guo T; Wang J; Song Q; Xu XJ; Hu SY; Wang YJ; Wang DC; Sun DZ; Zhang D; Xi T; Li HD; Zhang HB; Hang TJ; Lu HG; Liu JG
    Org Biomol Chem; 2015 May; 13(20):5656-73. PubMed ID: 25895552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties.
    Valenzano KJ; Miller W; Chen Z; Shan S; Crumley G; Victory SF; Davies E; Huang JC; Allie N; Nolan SJ; Rotshteyn Y; Kyle DJ; Broglé K
    J Pharmacol Exp Ther; 2004 Aug; 310(2):783-92. PubMed ID: 15054115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents.
    Stevens CW
    Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.
    Pan ZZ; Tershner SA; Fields HL
    Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man.
    Ur E; Wright DM; Bouloux PM; Grossman A
    Br J Pharmacol; 1997 Mar; 120(5):781-4. PubMed ID: 9138682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.